Mutations in the YAP gene are not frequent, but recurrent YAP1-MAML2 and YAP1-NUTM1 fusions have been identified as activators of Hippo-YAP pathway signaling in skin cancers and several other cancer types26,27. The gene discussed is YAP1; the disease is cancer.